- You're at
- Home /
- Judging and Jurors
2008 Jurors
Members of the MDEA jury are selected each year by a panel of editors from Canon Communications. The jury panel typically encompasses experts from a wide range of healthcare- and design-related fields, including clinical practice, biomedical engineering, human factors, industrial design, manufacturing, and other areas.
When considering juror nominees, Canon’s editors pay particular attention to the need for a balanced, multidisciplinary, and impartial jury. For this reason, jurors cannot be affiliated with a company that is submitting a product for consideration.
MDEA jurors have set a high standard for judging excellence and fair competition. Following are the jurors who will be evaluating entries in the 2008 MDEA competition.
Kouros Azar—Dr. Azar is a biomedical engineer and a practicing plastic surgeon with a specialization in complex reconstructive and aesthetic surgical techniques using innovative technologies. He holds several patents on new technologies used in the operating room. After receiving his BS in biomedical and electrical engineering in 1990 and his MD in 1995 from Case Western Reserve University, he completed a general surgery residency at the University of Arizona in 2000. He also completed a fellowship in plastic and reconstructive surgery at the University of Utah in 2002. He is on the executive committee of the Engineering in Medicine and Biology section of the Institute of Electrical and Electronics Engineers (IEEE). He is also a member of the Biomedical Engineering Society, the American Society for Reconstructive Microsurgery, and the American Society of Plastic and Reconstructive Surgeons, and is a diplomate of the American Board of Plastic Surgery. Azar has received an outstanding speaker award from IEEE’s Engineering in Medicine section as well as the Alpha Omega Alpha Medical Honor Society Award for research presented at the Irwin Lepow research day. From 1990 to 1995, Azar served as head engineer and scientist for all collaborative projects in the departments of otolaryngology and biomedical engineering at the Cleveland Clinic Foundation.
Kouros Azar, MD, 2100 Lynn Rd., Ste. 100, Thousand Oaks, CA 91360
Phone: 805/373-7073; Fax: 805/373-1116; E-mail: kazarmd@yahoo.com.
Laura Bix (alternate juror; inactive for 2008)—Dr. Bix started as an assistant professor at the School of Packaging at Michigan State University in January of 2002, after receiving her PhD in packaging the previous year. She specializes in healthcare packaging at the school and has taught courses in the principles of packaging, plastics and packaging, scientific writing, polymeric packaging, and medical packaging. She has been nominated, and is currently being considered, for an excellence in teaching award. A member of ASTM International, Bix has served as vice chair of the organization’s committee D10.32 on consumer, pharmaceutical, and medical packaging since 2004 and as a member of committee F02 on flexible barrier material since 2002. She is also a member of the Institute of Packaging Professionals (IoPP). Bix served as a juror for the 2004 Medical Design Excellence Awards, as a juror for the AmeriStar packaging design awards in 2004 and 2005, and as a juror for the Glass Packaging Institute’s 2006 Clear Choice Awards. She is on the editorial boards of the Journal of Testing and Evaluation (West Conshohocken, PA) and Pharmaceutical and Medical Packaging News (Los Angeles, CA), and serves on the advisory boards of Shelf Impact! (Chicago, IL) and Medical Device Developments (Nottingham, UK). Additionally, she is a member of the Include Network of the Royal College of Art (London).
Laura Bix, PhD, Assistant Professor, Michigan State University, School of Packaging, 153 Packaging Bldg., East Lansing, MI 48824
Phone: 517/355-4556; Fax: 517/353-8999; E-mail: bixlaura@msu.edu.
Warren S. Grundfest (alternate juror; inactive for 2008)—Dr. Grundfest holds appointments at the University of California at Los Angeles (UCLA) as a professor of bioengineering and electrical engineering in the School of Engineering, and a professor of surgery in the School of Medicine. He is one of the nation’s foremost experts on medical imaging. His research interests include minimally invasive surgery, microendoscopy, laser technology, biologic spectroscopy, and noninvasive optical diagnostics. Among other positions, he is president of the International Brain Mapping and Intraoperative Surgical Planning Society, a member of the board of directors of the United Cerebral Palsy foundation, a member of several diagnostic and therapeutic review sections for the National Institutes of Health, a member of review panels for the Institute for Biologic Sciences, and a member of the board of directors of the American Society for Laser Medicine and Surgery. Dr. Grundfest has received the Stein-Oppenheimer Award for Cancer Imaging and is a member of the NASA Space Technology Hall of Fame. He is a fellow of the American College of Surgeons, the American Institute for Medical and Biologic Engineers, and SPIE. He is a member of the American Society of Gastrointestinal and Endoscopic Surgeons and the Society for Endovascular Surgery, and is involved in numerous review, editorial, and program selection activities. He holds 15 patents and has two more pending; has published 184 papers, 46 book chapters, and 186 abstracts; has edited 16 books; and has been involved with a plethora of corporate technology development programs. Dr. Grundfest is a consultant to the FDA Office of Device Evaluation and to the United States Army’s West Coast Telemedicine and Advanced Technology Research Center (TATRC). He holds memberships in 18 engineering and medical professional societies. He holds a BA in biology and chemistry from Swarthmore (PA) College and an MD from Columbia University (New York City). Before assuming his latest position at UCLA in 1999, he was a research professor of biomedical engineering at the University of Southern California and director of laser research and technology development at Cedars-Sinai Medical Center (both in Los Angeles).
Warren S. Grundfest, MD, Professor of Bioengineering and Electrical Engineering, UCLA School of Engineering, Professor of Surgery, UCLA School of Medicine, 7523 Boelter Hall, Box 951600,
University of California at Los Angeles, Los Angeles, CA 90095-1600
Phone: 310/794-5550; Fax: 310/794-5956; E-mail: warrenbe@seas.ucla.edu.
Ogan Gurel—Dr. Gurel is chairman of the Aesis Research Group LLC, a firm that provides strategic and international marketing, market forecasting, technology assessment, and investment research services to companies and investment firms in the life sciences and healthcare sectors. Gurel also serves on the board of FireFly Medical, a company that designs and develops next-generation healthcare equipment, and he is also an adjunct associate professor of bioengineering at the University of Illinois–Chicago.
Gurel was previously chief executive officer at Duravest Inc., a publicly traded holding company with a specialty in convergent medical technologies. Prior to that he was vice president and medical director at Sg2 LLC, a leading healthcare intelligence think-tank and consultancy serving hospitals and health systems. Gurel’s business background also includes management consulting at Booz, Allen & Hamilton, and as an independent consultant to several medical device firms.
Dr. Gurel also has extensive experience in the basic biomedical sciences. He earned a BA cum laude in biochemical sciences from Harvard University, and afterward served as a visiting researcher at the Institut Laue-Langevin (Grenoble, France). During that time he conducted nuclear magnetic resonance structural studies of DNA and neutron diffraction analyses of membrane protein structure. He also holds an MPhil degree in biochemistry and molecular biophysics from Columbia University, where his research involved x-ray crystallographic structural studies of cytokines. His work has been published in the peer-reviewed scientific literature, including the European Molecular Biology Organization (EMBO) Journal and the Journal of Molecular Biology. He has also conducted research in computer science, winning third place in the national Westinghouse (now Intel) Science Talent Search. Dr. Gurel has taught a number of subjects—cellular and molecular biology, neuroanatomy, bioinformatics, and mathematical modeling—at several universities, including Columbia, Harvard, and Roosevelt universities.
On the clinical side, Gurel received his MD with honors (Alpha Omega Alpha) from the Columbia University College of Physicians and Surgeons. He completed a surgical internship at Massachusetts General Hospital with a joint appointment as clinical fellow in surgery at the Harvard Medical School. Dr. Gurel is also experienced in international medical relief work, having served during both the NATO military campaign in Kosovo as well as in Turkey after the massive 1999 earthquake. With extensive experience in international settings, he is fluent in French, Turkish, and German, and has conversational ability in Russian.
As a healthcare technology expert and futurist, Dr. Gurel is a frequent conference speaker worldwide, addressing the issue of emerging technologies and their impact on the future of healthcare. He has focused in particular on convergent medical technologies, including medical nanotechnology. He is a regular online columnist for Midwestbusiness.com, the Wisconsin Technology Network, and the Redington Life Sciences Newsletter. Additionally, his commentaries have been published in prominent print publications, including the Wall Street Journal.
Ogan Gurel, MD, Chairman, Aesis Research Group LLC, P.O. Box 578025, Chicago, IL 60657-8025
Phone: 312/246-5160; Fax: 773/409-5897; E-mail: gurel@aesisgroup.com.
Balakrishna Haridas (alternate juror; inactive for 2008)—Dr. Haridas is director of the National Science Foundation Minimally Invasive Medical Technologies Center (MIMTeC) and an associate professor in the department of biomedical engineering at the University of Cincinnati. MIMTeC is a government-and-industry sponsored research center focusing on the enabling of minimally invasive interventions. Haridas researches the biomechanics of soft tissues, focusing on endovascular interventions for vascular disease, minimally invasive surgery, and pelvic-floor disorders. At the university, he teaches in its medical device innovation program. Haridas is also founder and president of Device & Implant Innovations LLC (Mason, OH), a research and consulting company focused on the creation of intellectual property for clients through biomedical engineering innovations and advanced computational modeling technologies. His consulting work includes projects in cardiovascular devices, wound healing products, orthopedics, minimally invasive surgery, drug delivery systems, and polymer materials processing and characterization. Before he took these positions, he was a principal of Stress Engineering Services Inc. (Mason, OH) and founder/director of its medical device technologies business practice. Haridas is a member of the American Society of Mechanical Engineers. He is an associate editor and reviewer for the Journal of Biomechanical Engineering special issue on medical device design, and a reviewer for the Journal of Biomechanics and Modeling in Mechanobiology and Ultrasound in Medicine and Biology. Haridas holds six patents, has published a number of peer-reviewed articles, and has given dozens of conference presentations. He holds a BE in civil engineering from Bangalore University (India), an MS in engineering mechanics from the University of Alabama (Tuscaloosa), and a PhD in engineering mechanics/biomechanics from the University of Cincinnati.
Balakrishna Haridas, PhD, Associate Professor and Director, Minimally Invasive Medical Technologies Center, an NSF Industry/University Cooperative Research Center, Colleges of Engineering and Medicine,
846 Engineering Research Center, University of Cincinnati, Cincinnati, OH 45221.
Phone: 513/556-3745; Fax: 513/556-4162; E-mail: bala.haridas@uc.edu.
William A. Hyman (alternate juror; activated for 2008)—Dr. Hyman is a professor of biomedical engineering at Texas A&M University (TAMU; College Station, TX). Hyman holds an ScD in engineering mechanics and an MS in engineering mechanics from Columbia University, and a BSME in mechanical engineering from The Cooper Union. He is also senior scientist in the biomaterials research center at the University of Texas–Houston, a faculty member in material science and engineering at TAMU, and a participating faculty member in TAMU’s sports medicine institute and the center for microencapsulation and drug delivery. Hyman has served as a consultant for FDA, the National Science Foundation, the National Institutes of Health, the U.S. Army, the General Accounting Office, and in patent and personal-injury litigation. Among Hyman’s honors are a National Defense Education Act fellowship in biomechanics, the Sony award lectureship of the Society for Engineering in Urology, the Lockheed Martin award for excellence in engineering teaching, and the college Charles W Crawford service award. He holds memberships in the American Society for Testing and Materials (ASTM), the American College of Clinical Engineering (ACCE), the Association for the Advancement of Medical Instrumentation, the Biomedical Engineering Society, and the Human Factors and Ergonomics Society technical group on medical systems and functionally impaired populations. Hyman serves on the ASTM committees on surgical implants and medical devices, sports equipment and facilities, and forensic sciences, and is a board member of the U.S. Board of Examiners for Clinical Engineering, and of the ACCE Healthcare Technology Foundation. He is also a member of the Dallas region FDA-industry coalition.
Dr. Hyman is a registered professional engineer in Texas.
William A. Hyman, ScD, MS, PE, Professor, Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, TX 77843-3120
Phone: 979/845-5593, Fax: 979/845-4450, E-mail: w-hyman@tamu.edu.
Edmond W. Israelski—Dr. Israelski is human factors program manager for Abbott Laboratories (Abbott Park, IL). He has participated in the user interface design and evaluation of a wide variety of medical products, including infusion pumps, drug delivery systems, glucose meters, vascular intervention devices, and diagnostic testing systems. As part of his post, he created an infrastructure to embed human factors process steps in all aspects of design and evaluation of new products. Before joining Abbott in 2001, he was chief technology officer for consulting group Human Factors International, and held human factors positions at SBC-Ameritech and Bell Labs/Lucent Technologies. Dr. Israelski is cochair of the Association for the Advancement of Medical Instrumentation human factors engineering standards committee. He is a member of the International Organization for Standardization/International Electrotechnical Commission joint working group on usability for medical devices, and a member of the National Academy of Science committee on human-system design support. He is a fellow of the Human Factors and Ergonomics Society and a member of numerous other associations. He is a board-certified human factors professional and holds 15 patents. He has authored a wide range of journal papers, trade magazine articles, and book chapters, and has served as an expert witness on usability issues. Dr. Israelski holds a BS in electrical engineering from the New Jersey Institute of Technology (Newark, NJ), an MS in operations research from Columbia University (New York City), and a PhD in engineering/industrial psychology (human performance) from Stevens Institute of Technology (Hoboken, NJ).
Edmond W. Israelski, PhD, Human Factors Program Manager, Corporate Regulatory and Quality,
Abbott Laboratories, 610 Dock Dr., Lake Barrington, IL 60010
Phone: 847/382-9280; E-mail: ed.israelski@abbott.com.
Craig M. Jackson (alternate juror; activated for 2008)—Dr. Jackson is president of Hemosaga Diagnostics Corp., a start-up company in San Diego. Prior to founding Hemosaga Diagnostics, he operated a San Diego–based consulting practice. Jackson has served as president and director of research and development for Reagents Applications Inc. and as scientific director for the American Red Cross Blood Services (Detroit) where he was also an adjunct professor of biochemistry at Wayne State University. He was a professor of biological chemistry and an associate professor of internal medicine at Washington University School of Medicine (St. Louis) prior to joining the American Red Cross. He has been a visiting professor at Kyushu University (Fukuoka, Japan) and the University of Hawaii. Jackson is a member of the editorial advisory board for IVD Technology magazine. He has written more than 75 original papers, contributed to more than 30 textbooks, writes regularly for both professional and trade journals, and holds several patents. He is a member of Working Group 1 of the Joint Committee for Traceability in Laboratory Medicine (JCTLM), an organization founded by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the Bureau International des Poids et Mesures (BIPM), and the International Laboratory Accreditation Cooperation (ILAC). JCTLM provides the mechanism by which the European Union’s In Vitro Device Directive requirement for traceability can be met. On the JCTLM, Jackson has led the team that has developed the quality system. Jackson received a BS degree from Washington State University (Pullman, WA) and a PhD from the University of Washington (Seattle). He is a fellow of the National Academy of Clinical Biochemistry (Washington, DC) and also a fellow of the American Association for the Advancement of Science (Washington, DC).
Craig M. Jackson, PhD, President and Chief Technical Officer, Hemosaga Diagnostics Corp.,
5931 Seacrest View Rd., San Diego, CA 92121-4355
Phone: 858/638-0957; E-mail: cjackso2@san.rr.com.
Eliot Lazar (alternate juror; inactive for 2008)—Dr. Lazar is principal of elCON Medical (Buffalo, NY), a consulting firm that provides an end-user medical and surgical perspective on medical device market needs and requirements, medical technology trends and developments, and funding strategies. The company collaborates with medical device and pharmaceutical companies on numerous fronts, works extensively with financial institutions, and provides a key interface between these institutions and leading clinicians. An ophthalmologist specializing in anterior segment pathology and surgery, Lazar has several university appointments. He holds patents on ophthalmic instruments, has published numerous papers, and regularly presents research findings at medical society meetings. His professional memberships include the American Medical Association (Chicago), the American Society of Cataract and Refractive Surgery (Fairfax, VA), the Society for Neuroscience (Washington, DC), the International Society for Eye Research (San Francisco), and the Association for Research in Vision and Ophthalmology (Rockville, MD). Lazar has a BA degree from the University of Pennsylvania (Philadelphia), an MS from the State University of New York (Buffalo), and an MD from Georgetown University (Washington, DC).
Eliot Lazar, MD, President, elCON Medical Consulting, 126 Devonshire Rd., Buffalo, NY 14223
Phone: 716/662-3211; Fax: 716/877-7437; Cell: 716/308-7290; E-mail: elconmed@hotmail.com.
Pascal Malassigné—Mr. Malassigné is a professor of industrial design at the Milwaukee Institute of Art and Design, a research industrial designer at the Milwaukee Veterans Affairs Medical Center, and an adjunct assistant professor of rehabilitation at the Medical College of Wisconsin in Milwaukee. He is one of the nation’s foremost designers of assistive and mobility products for the elderly and those with disabilities. For the past 22 years, his research has been funded by the U.S. Department of Veterans Affairs and has led to the design of products from commode-shower wheelchairs to bathing fixtures, prone carts, and bedrails. Malassigné has more than 30 years of experience teaching industrial design, and taught at Georgia Tech and Virginia Tech universities before coming to Milwaukee in 1991. He is a visiting evaluator for the National Association of Schools of Art & Design, for which he accredits industrial design programs. He has authored more than 70 articles and papers and has made numerous presentations nationally and internationally on topics ranging from design education to rehabilitation technology. Malassigné is a member of the Human Factors and Ergonomics Society, the Rehabilitation Engineering Society of North America, and the Industrial Designers Society of America (IDSA), in which he was made a fellow member in 2001 in honor of his service to the industrial design profession and IDSA. He helped found and was the first president of the Design Foundation, IDSA’s nonprofit organization. In 2006, Design Intelligence named him one of the nation’s most admired industrial design educators.
Pascal Malassigné, MID, Professor, Industrial Design, Milwaukee Institute of Art and Design, 273 E. Erie St., Milwaukee, WI 53202
Phone: 414/291/8069; Fax: 414/291-3267; E-mail: pmalassi@miad.edu.
Jerry K. McVicker—Dr. McVicker is Chief Operations Officer for Sirrah Bios (Ames, IA), which develops and manufactures veterinary vaccines. The company prepares recombinant, subunit vaccine antigens via a vector platform which could be described as “plug and play”. McVicker is also an assistant professor in the animal science department at Iowa State University (Ames, IA). He has published a number of papers on topics ranging from animal fertility diagnostics to bovine immunoglobulin G detection. He holds patents on two antibody testing methods. Before joining Midland in 1993, McVicker was assistant manager of research and development and quality control for Fort Dodge Animal Health (Fort Dodge, IA). He serves on the reader board of IVD Technology magazine and is a member of the American Association for Clinical Chemistry, American Dairy Science Association and the American Veterinary Biological Association. McVicker received his BS degree in biochemistry and his MS and PhD degrees in immunobiology from Iowa State in 1988, 2000, and 2004, respectively.
Jerry McVicker, PhD, Chief Operations Officer, Sirrah Bios, 2325 N. Loop Dr., Ames, IA 50010
Phone: 515/296-3984; Fax: 515/296-3985; E-mail: jmcvicker@sirrah-bios.com.
Sandra J. Miller—Ms. Miller is managing director of the Stanford Biodesign Program at Stanford University (Palo Alto, CA). The program fosters interdisciplinary research and education in medical device design and commercialization. As a liaison to the university’s Office of Technology Licensing, she helps assess medical device technology commercial viability and provides strategic input for marketing and licensing. She has developed several new programs, including the Biodesign pathway for medical device fellowships at FDA’s Center for Devices and Radiological Health. She has coorganized some of the program’s activities related to national policy, such as conflicts of interest and biomedical ethics. Ms. Miller also manages the bioengineering department’s translational research partnership award from the Wallace H. Coulter Foundation, a grant program related to commercializing research projects. She is a founding member of the Stanford Entrepreneurship Network, whose mission is to support entrepreneurship education, research, and collaboration. Before she took her current positions, she produced physician education materials on new cardiovascular technologies for the Stanford Medical School. She has given presentations and authored articles based on topics in technology transfer and innovation. She holds a BA in broadcast communications from San Jose State University (San Jose, CA), and an MBA from Pepperdine University (Malibu, CA).
Sandra J. Miller, MBA, Managing Director, Stanford Biodesign Program, 318 Campus Dr., Rm. E100, Stanford, CA 94305-5428.
Phone: 650/736-1162; Fax: 650/724-8696; E-mail: sandy.miller@stanford.edu.
E. William Schneeberger (alternate juror; inactive for 2008)—Dr. Schneeberger is a cardiothoracic surgeon at the University of Cincinnati Medical Center’s department of surgery, division of cardiac surgery. He is engaged in research to treat cardiac failure and surgical treatment of atrial fibrillation. He has a particular interest in minimally invasive cardiac surgery, surgical treatment for atrial fibrillation, and robotics. Since joining the University of Cincinnati in 2003, he has worked on three medical device development projects and has proctored new procedures for the surgical treatment of atrial fibrillation. His current research involves studying doppler wire-derived measurement of coronary flow reserve, coronary pressure wire-derived fractional flow reserve, and intravascular ultrasound imaging. He is also working on the development of a mechanical left heart assist device. Born and educated in South Africa, Dr. Schneeberger moved to the United States in 1999, and worked in the cardiothoracic surgery division at the Ohio State University Medical Center before taking his post at the University of Cincinnati. Dr. Schneeberger earned his medical degree from the University of Cape Town, South Africa, and served his internship at the University of Natal Hospitals in Durban. He then served two years as a medical officer in the South African Defense Force. After becoming a cardiothoracic surgery fellow of the College of Surgeons of South Africa, he was on the faculty of the University of Natal Medical School and a consulting surgeon in the University Hospitals.
E. William Schneeberger, MB, ChB, Department of Surgery, Division of Cardiac Surgery, Section of Cardiothoracic Surgery, University of Cincinnati Medical Center, 3905 Ledgewood Dr., Cincinnati, OH 45229
Phone: 513/260-6957; E-mail: bill_schnee@yahoo.com.
Molly Follette Story—Ms. Story is president of Human Spectrum Design LLC, and codirector of the Rehabilitation Engineering Research Center on Accessible Medical Instrumentation.
Story is an expert in universal design of products and in the accessibility and usability of medical instrumentation. She is coeditor of the recent book, Medical Instrumentation: Accessibility and Usability Considerations (CRC Press, 2007). She also coordinated development of and helped author the Principles of Universal Design, and coauthored with James L. Mueller and the late Ronald L. Mace the book, The Universal Design File: Designing for People of All Ages and Abilities(North Carolina State University, 1998).
Story is a member of the Human Factors and Ergonomics Society (HFES), the Association for the Advancement of Medical Instrumentation (AAMI), the Rehabilitation Engineering and Assistive Technology Society of North America (RESNA), and the Industrial Designers Society of America (IDSA). She is also a member of AAMI’s human factors engineering committee, which is developing the forthcoming AAMI HE75 standard on human factors design guidelines for medical devices.
Story is also a PhD candidate in the ergonomics program in the School of Public Health at the University of California, Berkeley.
Molly Follette Story, President, Human Spectrum Design LLC, 3717 Deauville Pl., Santa Rosa, CA 95403
Phone: 707/578-6839; Fax: 707/578-9435; E-mail: molly@humanspectrumdesign.com
Robert Virag (alternate juror; inactive for 2008)—Mr. Virag is founder and principal of two medial device consulting firms—Trifid Medical Group LLC and Alveoli Medical LLC—that provide research, development, and engineering management services for anesthesiology, respiratory, and critical-care devices. For Trifid, he advises clients on all aspects of medical device design, development, and commercialization. For Alveoli, he has teamed with inventors to develop novel adjuncts to mechanical ventilation and offers testing services for respiratory equipment manufacturers. Before founding his own firms, he served as director of technology development for Tyco Healthcare’s respiratory division, senior director of R&D for Mallinckrodt Inc., and group engineering manager for Baxter Healthcare. He is an inventor named on 19 U.S. patents. Virag serves on the board of directors and scientific evaluation committee of the Anesthesia Patient Safety Foundation, and is a former Small Business Innovation Research grant reviewer for the National Science Foundation. He is a member of the American Association of Respiratory Care, the Regulatory Affairs Professionals Society, and the Product Development Management Association. He is chairman of ASTM subcommittee F29.19 on patient-warming equipment standards, as well as coconvener of an International Organization for Standardization/International Electrotechnical Commission joint working group for patient-warming equipment. He also serves FDA’s Center for Devices and Radiological Health as a United States agent for devices, representing international device manufacturers. Virag holds a BS in biology from the University of Illinois, Chicago, and an MS in management from the Lake Forest School of Management.
Robert Virag, MS, Principal, Trifid Medical Group LLC, 14337 Cypress Hill Dr., Chesterfield, MO 63017
Phone: 314/878-4620; Fax: 309/218-1129; E-mail: rvirag@trifidmedical.com.
Herbert F. Voigt—Dr. Voigt is president and a fellow of the American Institute for Medical and Biological Engineering (Washington, DC) and president of Alpha Eta Mu Beta, the national biomedical engineering honor society. In August 2006, Voigt was elected vice president of the International Federation for Medical and Biological Engineering (IFMBE). He will assume the IFMBE presidency at the organization’s 2009 world congress in Munich, and he will preside over IFMBE's general assembly in Beijing in 2012. He is a past president and a fellow of the Biomedical Engineering Society (Landover, MD). Voigt is a professor in the department of biomedical engineering at Boston University and also a research professor in the university's department of otolaryngology. He has published numerous articles in the Journal of Neurophysiology, Hearing Research, Biological Cybernetics, and the Annals of Biomedical Engineering. He is the recipient of grants for hearing research, for providing research experience for undergraduates in biomedical engineering, and for enhancing internship opportunities for biomedical engineering undergraduates. He received a BE degree in electrical engineering from the City College of New York (New York City) and a PhD in biomedical engineering from Johns Hopkins University (Baltimore), where he also did postdoctoral work in neural encoding.
Herbert F. Voigt, PhD, Professor of Biomedical Engineering, College of Engineering, Boston University,
44 Cummington St., Boston, MA 02215-2407
Phone: 617/353-2817; Fax: 617/353-6766; E-mail: hfv@bu.edu.
Mark S. Vreeke (alternate juror; inactive for 2008)—Dr. Vreeke is a senior partner at Rational Systems LLC (Houston), a business process and technical consulting firm. Rational Systems provides a consulting service that combines the business knowledge necessary to extract maximum value from a company’s assets and the technical capabilities to implement IT and infrastructure changes to support any business redesign. While at Rational Systems, Vreeke has been the lead consultant on multiple IVD projects ranging from blood glucose monitors to multianalyte clinical analyzers. In a related position, Vreeke is serving as vice president of R&D for Rational Biotechnology, a spin-off of Rational Systems, whose goal is to speed the adoption of personalized medicine through the development of combined IVD and drug therapy products. Before forming Rational Systems, Vreeke was a senior research scientist at Bayer Corp. (Elkhart, IN), where he was responsible for new reagent development in Bayer’s self-testing segment and coordinated efforts to incorporate new reagents into a next-generation sensor platform. He has also held research positions at SpectRx, and TheraSense Inc. He graduated from Calvin College with a BS in chemistry and went on to receive a PhD in analytical chemistry from the University of Texas. He is currently a member of the editorial advisory board of IVD Technology, and is a visiting professor in the chemical engineering department at the Universitat Rovira i Virgili (Terragona, Spain).
Mark S. Vreeke, PhD, Senior Partner, Rational Systems LLC, 14603 Cedar Point, Houston, TX 77070
Phone: 832/752-2915; E-mail: mark.vreeke@rationalsystems.com.
Michael E. Wiklund—Mr. Wiklund is president of Wiklund Research & Design Inc. (Concord, MA), a firm that helps companies develop safe, effective, usable, and appealing medical products. Board-certified in his profession, Wiklund’s experience as a project manager, principal researcher, and designer extends beyond medical devices to include consumer and scientific products, personal and business software, corporate and e-commerce Web sites, communications technology, and industrial equipment and workplaces. He is an adjunct associate professor in the engineering psychology program of the department of mechanical engineering at Tufts University. Wiklund has been a contributing editor to Medical Device & Diagnostic Industry magazine (MD&DI) since 1993, and is a member of the publication’s editorial advisory board. He has published numerous articles, books, and technical papers, and has also presented papers at professional conferences in the medical device, human factors, and scientific instrumentation fields. His most recent book, Designing Usable Medical Devices, coauthored with Stephen Wilcox, was published in early 2005. He is a member of the Human Factors and Ergonomics Society, the Industrial Designers Society of America, and the Association for the Advancement of Medical Instrumentation. Holding BS (civil engineering) and MS (engineering design/human factors) degrees from Tufts University, Wiklund is also a professional engineer. In 2004, MD&DI named Wiklund to its list of 100 notable people in the medical device industry.
Michael E. Wiklund, MS, President, Wiklund Research & Design Inc., 152 Commonwealth Ave.,
Concord, MA 01742
Phone: 978/371-2700; E-mail: michael@wiklundrd.com.
- Judging Process and Criteria
- Juror Selection
- 2008 Jurors
- Juror Nominations
- MDEA Juror Nomination Form